Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
AChR, AOCI, bifurcation, ceased, currency, denominated, director, embedded, forty, hedge, hedged, hedging, hypothetical, Hytrulo, injunction, match, OCARINA, placebo, prospective, prospectively, retail, retrospective, RMS, spot
Removed:
accelerated, ASC, assembled, awarded, cardiac, COLUMBA, comparison, concentration, consistently, deal, Genmab, GPO, great, HR, IIIB, integrate, invent, isolated, Labour, magnitude, managing, Mayo, MHLW, Ministry, NMPA, NYHA, partial, Patheon, polyradiculoneuropathy, protein, recommended, response, retaining, revised, revision, Trough, undergoing, vendor, Welfare
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view